MyAverix Finance
HK · Healthcare
Genscript Biotech Corp (1548)
Biotechnology
Genscript Biotech Corp (1548) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $28.60B, P/E ratio is 18.00, net margin is -55.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1548
Genscript Biotech Corp (1548) — FAQ
What is Genscript Biotech Corp's market cap?
Genscript Biotech Corp (1548) has a reported market cap of $28.60B (data as of 2026-05-21).
What is 1548's P/E ratio?
The price-to-earnings (P/E) ratio for Genscript Biotech Corp (1548) is 18.00 (data as of 2026-05-21).
Does Genscript Biotech Corp pay a dividend?
Dividend yield is not available in the current snapshot for Genscript Biotech Corp (1548). Check the MyAverix Finance app for the latest dividend data.
What sector is Genscript Biotech Corp in?
Genscript Biotech Corp (1548) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 1548 listed on?
1548 is listed on HK.
What is Genscript Biotech Corp's net margin?
Genscript Biotech Corp (1548) reports a net margin of -55.5% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.